Whitehawk Therapeutics (WHWK) Non Operating Income (2016 - 2026)

Whitehawk Therapeutics (WHWK) has 11 years of Non Operating Income data on file, last reported at $1.3 million in Q1 2026.

• Non Operating Income for Q1 2026 came in at $1.3 million, down 98.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (down 92.4% YoY), and the FY2025 annual result was $93.8 million, up 2390.15% from the prior year.
• Non Operating Income retreated to $1.3 million in Q1 2026 per WHWK's latest filing, from $1.6 million in the prior quarter.
• Over five years, Non Operating Income peaked at $88.2 million in Q1 2025 and troughed at -$43000.0 in Q1 2022.
• A 5-year average of $6.3 million and a median of $1.4 million in 2023 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2025 and 2026: Non Operating Income soared 7114.55% in 2025, then sank 98.49% in 2026.
• A 5-year view of Non Operating Income shows it stood at $1.5 million in 2022, then fell by 6.77% to $1.4 million in 2023, then tumbled by 53.22% to $676000.0 in 2024, then jumped by 142.01% to $1.6 million in 2025, then decreased by 18.83% to $1.3 million in 2026.
• Business Quant data shows WHWK's Non Operating Income at $1.3 million in Q1 2026, $1.6 million in Q4 2025, and $1.8 million in Q3 2025.